De novo Design of SARS-CoV-2 Main Protease Inhibitors

被引:9
|
作者
Fischer, Christian [1 ]
Veprek, Nynke A. [1 ,2 ]
Peitsinis, Zisis [1 ]
Ruhmann, Klaus-Peter [1 ]
Yang, Chao [1 ]
Spradlin, Jessica N. [3 ]
Dovala, Dustin [4 ]
Nomura, Daniel K. [3 ]
Zhang, Yingkai [1 ]
Trauner, Dirk [1 ]
机构
[1] NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA
[2] Ludwig Maximilians Univ Munchen, Dept Chem, Butenandtstr 5-13, D-81377 Munich, Germany
[3] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA
[4] Novartis Inst BioMed Res, Emeryville, CA 94608 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
viral main protease; small-molecule inhibitor; SARS-CoV-2; coronavirus; molecular modeling;
D O I
10.1055/a-1582-0243
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, M-Pro , is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar noncovalent inhibitors of the viral main protease.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 50 条
  • [1] Potent and biostable inhibitors of the main protease of SARS-CoV-2
    Tsuji, Kohei
    Ishii, Takahiro
    Kobayakawa, Takuya
    Higashi-Kuwata, Nobuyo
    Azuma, Chika
    Nakayama, Miyuki
    Onishi, Takato
    Nakano, Hiroki
    Wada, Naoya
    Hori, Miki
    Shinohara, Kouki
    Miura, Yutaro
    Kawada, Takuma
    Hayashi, Hironori
    Hattori, Shin-ichiro
    Bulut, Haydar
    Das, Debananda
    Takamune, Nobutoki
    Kishimoto, Naoki
    Saruwatari, Junji
    Okamura, Tadashi
    Nakano, Kenta
    Misumi, Shogo
    Mitsuya, Hiroaki
    Tamamura, Hirokazu
    ISCIENCE, 2022, 25 (11)
  • [2] Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
    Thakur, Abhishek
    Sharma, Gaurav
    Badavath, Vishnu Nayak
    Jayaprakash, Venkatesan
    Merz, Kenneth M., Jr.
    Blum, Galia
    Acevedo, Orlando
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2022, 13 (25) : 5776 - 5786
  • [3] Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
    Baev, Dmitry S.
    Blokhin, Mikhail E.
    Chirkova, Varvara Yu.
    Belenkaya, Svetlana V.
    Luzina, Olga A.
    Yarovaya, Olga I.
    Salakhutdinov, Nariman F.
    Shcherbakov, Dmitry N.
    MOLECULES, 2023, 28 (01):
  • [4] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Katre, Soumya Gulab
    Asnani, Alpana Jagdish
    Pratyush, Kumar
    Sakharkar, Nilima Gangadhar
    Bhope, Ashwini Gajanan
    Sawarkar, Kanchan Tekram
    Nimbekar, Vaibhav Santosh
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
  • [5] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
    Ahmad, Fawad
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad Ur
    Khattak, Saeed Ullah
    Butt, Sadia
    Mushtaq, Maryam
    SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
  • [6] Progress of SARS-CoV-2 Main protease peptide-like inhibitors
    Liu, Xiaoyong
    Ren, Xiaoli
    Hua, Miao
    Liu, Fang
    Ren, Xiaoping
    Sui, Chaoya
    Li, Qing
    Luo, Fen
    Jiang, Zhiyong
    Xia, Ziqiao
    Chen, Jingxia
    Yang, Bing
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [7] Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
    Ghahremanpour, Mohammad M.
    Tirado-Rives, Julian
    Deshmukh, Maya
    Ippolito, Joseph A.
    Zhang, Chun-Hui
    de Vaca, Israel Cabeza
    Liosi, Maria-Elena
    Anderson, Karen S.
    Jorgensen, William L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (12): : 2526 - 2533
  • [8] Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
    Hemmati, Seyed Ali
    Tabein, Saeid
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 142
  • [9] Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
    Mahdi, Mohamed
    Motyan, Janos Andras
    Szojka, Zsofia Ilona
    Golda, Maria
    Miczi, Mario
    Tozser, Jozsef
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [10] 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
    Forrestall, Katrina L.
    Burley, Darcy E.
    Cash, Meghan K.
    Pottie, Ian R.
    Darvesh, Sultan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 335